Skip to Main Content

Paper Details

A risk stratification model for toxicities in phase 1 immunotherapy trials.
Eur J Cancer
0
2022
Author NameAffiliation
Lillian L SiuPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 1

Datasets

Release 1.2